Sleep Disorders

Here’s how we can help improve quality of sleep in both our patients and ourselves.

What is new in research on sleep?

What is new in research on seasonal affective disorder?

Did you miss the 2023 Annual Psychiatric Times World CME Conference? Don't worry, we've got you covered.

What is new in research on ADHD?

From sleep disturbances in ADHD to psychotherapy for treatment-resistant depression, here are highlights from the week in Psychiatric Times.

What is the impact of ADHD on sleep? Researchers performed a systematic review and meta-analysis of objectively measured sleep in children and adolescents with ADHD.

"During the past 5 years has gabapentin retained its position as one of the top 10 drugs prescribed in the United States."

From sleep and neuroendocrine function following TBI to new phase 3 results from a clinical trial evaluating a promising new schizophrenia treatment, here are highlights from the week in Psychiatric Times.

Sleep and neuroendocrine function are disrupted following TBI.

What are the treatment options for insomnia when avoiding benzodiazepines? John W. Winkelman MD, PhD, shares insights and guidance at the 2023 Annual Psychiatric Times World CME Conference.

From long-acting injectable antipsychotics for managing schizophrenia to mental health responses to the recent conflict in Israel, here are highlights from the week in Psychiatric Times.

What is new in research on schizophrenia?

The newest class of medications to treat insomnia have many advantages.

What is the nature of the relationship between psychosis and sleep disorders?

Does early improvement in insomnia predict response to pharmacotherapy in psychotic depression? Authors performed a secondary analysis of a randomized clinical trial.

"Cumulatively, the findings of such reports have led to a concerted effort to encourage physicians to monitor patients for manic symptoms on initiation, reintroduction, and dose modulation of corticosteroid therapy."

What is new in research on sleep?

From cannabis use disorder and schizophrenia to social media use and youth mental health, here are highlights from the week in Psychiatric Times.

The study explored the intervention’s effects using both quantitative and qualitative methods.

From new research on psilocybin as a treatment for MDD to new FDA approvals for ADHD and BED, here are highlights from the week in Psychiatric Times.

Researchers investigated the prevalence and correlates of sleep disorders in patients with first-episode psychosis.

What's new in sleep research?

From TMS as a treatment for long COVID to an update on 988 and crisis care, here are highlights from the week in Psychiatric Times.

According to recent research, sleep problems were a common symptom in a large study of patients with first-episode psychosis.

Emergency department records reveal that youth experiencing disrupted sleep are at greater risk for suicidal thoughts and behaviors.

From overutilization of emergency departments to reversible clomiphene-associated manic episodes, here are highlights from the week in Psychiatric Times.

What can we learn from sleep in schizophrenia? New research sheds light.

What risk does clomiphene use present to patients?

How does schizophrenia differ between men and women, and what does this mean for developing treatment strategies?